MedPath

Group study of UFT following instillation of anticancer drug for superficial bladder cancer

Not Applicable
Conditions
on-muscle Invasive Bladder Cancer
Registration Number
JPRN-UMIN000005596
Lead Sponsor
niversity of Tokyo, Department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
252
Inclusion Criteria

Not provided

Exclusion Criteria

1)Recurrent cancer 2)UC in prostatic urethra 3)History of previous therapy with UFT or systemic chemotherapy or pelvic radiotherapy 4)Serious comorbidity 5)Contraindication for UFT 6)Women who is pregnant or possibly pregnant 7)Any contraindication investigator specify

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath